Micro X (ASX:MX1) - CEO, Peter Rowland
CEO, Peter Rowland
Source: SBS
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Australian hi-tech company Micro-X (MX1) has received $1.2 million in purchase orders for its digital X-ray system, Nano
  • The majority of these orders come from Australian customers
  • One such client is the New South Wales Government, who purchased x-ray systems as it prepares to combat COVID-19
  • This order represents the first major sale of Nano units on the Australian market, following Micro-X’s first placement at Alfred Hospital
  • It brings the total orders for Nano to $3.6 million since February 2020
  • On market close, Micro-X is up 12 per cent and is trading for 14¢ per share

Australian hi-tech company Micro-X (MX1) has received $1.2 million in purchase orders for its digital X-ray system, Nano.

The majority of these orders come from Australian customers. One such client is the New South Wales Government, who purchased x-ray systems as it prepares to combat COVID-19. The other $200,000 in purchase orders has been received from European and Asian markets.

This order represents the first major sale of Nano units on the Australian market, following Micro-X’s first placement at Alfred Hospital.

According to the company, Nano is a lightweight, digital medical x-ray system.

The recent purchase orders were generated by Quantum Health Group, a healthcare distribution company which specialises in medical imaging equipment throughout Asia.

As announced last week, the company has begun a major ramp-up in Nano production to meet growing demand for mobile x-ray imaging.

Managing Director Peter Rowland said there has been an explosion for the demand around the globe for imaging technology in the response to COVID-19.

“As Australian government agencies increase their state of readiness to image potentially many more Australian patients, we are very pleased that our locally developed and manufactured high-tech Nano is now helping Australians in these very challenging times,” he said.

“Our recent investment to ramp up Nano production and reduce delivery times will enable these additional orders to be filled promptly and for us to continue to meet expected ongoing demand for new orders as and when they are received,” he added.

This new order brings the total orders for Nano to $3.6 million since February 2020.

On market close, Micro-X is up 12 per cent and is trading for 14¢ per share.

MX1 by the numbers
More From The Market Online

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration…

Little Green Pharma closely eyeing USA’s legal downgrade of Cannabis danger

Overnight, the Biden government did something sure to give their counterparts a stir – the USA…

OncoSil’s cancer device shows shrink in pancreatic tumours

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide…
The Market Online Video

Why Princeton Professor rates BlinkLab’s autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and…